If I Could Buy Only 1 High-Yield Dividend Stock in October for Passive Income, This Would Be It
With the S&P 500 (^GSPC 0.53%) hovering around an all-time high, investors may be more interested in growth stocks with market-beating potential than high-yield dividend stocks. But long-term investors know that the true value of dividend stocks is the passive income they provide, no matter what the market is doing.
3 Defensive Stocks to Buy as Economic Uncertainty Lingers
Investors are advised not to fight the trend. Right now, the trend for stocks remains bullish.
The Clorox Company (CLX) Presents At Barclays 18th Annual Global Consumer Staples Conference 2025 Transcript
The Clorox Company (NYSE:CLX ) Barclays 18th Annual Global Consumer Staples Conference 2025 September 3, 2025 7:30 AM EDT Company Participants Linda Rendle - CEO & Chairman Luc Bellet - Executive VP & CFO Conference Call Participants Lauren Lieberman - Barclays Bank PLC, Research Division Presentation Lauren Lieberman MD & Senior Research Analyst Okay. We're going to get started.
3 Dividend Stocks Raising Payouts—and Backing It Up With Results
Not all dividends are paid out equally; some companies try to create a “trap” by overpaying on a quarter's dividend, attracting buyers through a short-term high dividend yield that seems too good to pass up. The realization comes much later, though, that these companies can't afford these payouts, straining the financial profile altogether and having to decrease or cancel these dividends later.
Is the Options Market Predicting a Spike in Clorox Stock?
Investors need to pay close attention to CLX stock based on the movements in the options market lately.
Clorox: Finally Some Good News, But Still Behind Management's Expectations (Rating Upgrade)
Upgrading Clorox from 'sell' to 'hold' as recent financials show organic volume and revenue growth, especially in the Health and Wellness segment. Gross margin improvements and cost optimization efforts are finally materializing, though results still lag behind top peers and management expectations. The valuation is now more reasonable after a 25% stock price decline, with EV/EBITDA multiples closer to the discount CLX deserves when compared to top market players, reducing downside risk.
Top 3 Undervalued Dividend Stocks to Buy In August
These dividend stocks are trading at big discounts. They may be close to bottoming out.
Clorox Q4 Earnings Beat Estimates, Organic Sales Increase Y/Y
CLX posts 57.7% EPS growth and 8% organic sales gain in the fourth quarter, fueled by strong ERP-driven volume increases.
The Clorox Company (CLX) Q4 2025 Earnings Call Transcript
The Clorox Company (NYSE:CLX ) Q4 2025 Earnings Conference Call July 31, 2025 5:00 PM ET Company Participants Linda J. Rendle - CEO & Chairman Lisah Burhan - Vice President of Investor Relations Luc Bellet - Executive VP & CFO Conference Call Participants Andrea Faria Teixeira - JPMorgan Chase & Co, Research Division Anna Jeanne Lizzul - BofA Securities, Research Division Bonnie Lee Herzog - Goldman Sachs Group, Inc., Research Division Christopher Michael Carey - Wells Fargo Securities, LLC, Research Division Filippo Falorni - Citigroup Inc., Research Division Javier T.
Compared to Estimates, Clorox (CLX) Q4 Earnings: A Look at Key Metrics
Although the revenue and EPS for Clorox (CLX) give a sense of how its business performed in the quarter ended June 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Clorox (CLX) Q4 Earnings and Revenues Top Estimates
Clorox (CLX) came out with quarterly earnings of $2.87 per share, beating the Zacks Consensus Estimate of $2.24 per share. This compares to earnings of $1.82 per share a year ago.
Countdown to Clorox (CLX) Q4 Earnings: A Look at Estimates Beyond Revenue and EPS
Beyond analysts' top-and-bottom-line estimates for Clorox (CLX), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended June 2025.
